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Abstract
Background: Cancer is a major health problem and exploiting natural products have been one of the
most successful methods to combat this disease. Verbesina encelioides is a notorious weed with various
pharmacological properties.
The aim of the present investigation was to screen the anticancer potential of V. encelioides extract against
human lung cancer (A-549), breast cancer (MCF-7), and liver cancer (HepG2) cell lines.
Methods: A-549, MCF-7, and HepG2 cells were exposed to various concentrations of (10–1000 μg/ml) of V.
encelioides for 24 h. Further, cytotoxic concentrations (250, 500, and 1000 μg/ml) of V. encelioides induced
oxidative stress (GSH and LPO), reactive oxygen species (ROS) generation, mitochondrial membrane
potential (MMP), cell cycle arrest, and DNA damage in HepG2 cells were studied.
Results: The exposure of cells to 10–1000 μg/ml of extract for 24 h, revealed the concentrations 250–
1000 μg/ml was cytotoxic against MCF-7 and HepG2 cells, but not against A-549 cells. Moreover, the
extract showed higher decrease in the cell viability against HepG2 cells than MCF-7 cells. Therefore, HepG2
cells were selected for further studies viz. oxidative stress (GSH and LPO), reactive oxygen species (ROS)
generation, mitochondrial membrane potential (MMP), cell cycle arrest, and DNA damage. The results
revealed differential anticancer activity of V. encelioides against A-549, MCF-7 and HepG2 cells. A significant
induction of oxidative stress, ROS generation, and MMP levels was observed in HepG2 cells. The cell cycle
analysis and comet assay showed that V. encelioides significantly induced G2/M arrests and DNA damage.
Conclusion: These results indicate that V. encelioides possess substantial cytotoxic potential and may
warrant further investigation to develop potential anticancer agent.
Keywords: Verbesina encelioides, Cytotoxicity, Oxidative stress, ROS generation, MMP, DNA damage
Background
Cancer is one of the main causes of human death in de-
veloped and developing countries [1–3]. 15 million new
cases of cancer are expected, 70 % of which will be in
developing countries by 2020, where governments are
less prepared to address the growing cancer burden
[4]. Lung cancer, breast cancer, and liver cancer were
the most common sites of cancer diagnosed in 2012
among men and women [5]. The growing trend indi-
cates deficiency in the present cancer therapies and
the average survival rates are less [6]. An accurate
and effective treatment of the cancer is very much
required for diagnosis of the specific type of cancer
diseases. Every cancer type requires a specific course
of therapy that includes one or more modalities such
as surgery, and/or radiotherapy, and/or chemotherapy
[7, 8]. Therefore, there is an urgent need to explore
anti-cancer drugs with higher efficacy with less side
effects and an affordable cost [9]. Chemotherapy is
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the most effective method of cancer treatment that
uses chemical substances, especially one or more
chemotherapeutic agents [10]. Alternative and com-
plementary medicines play an emerging role in the
cancer prevention. Plants are the best alternative, as
they provide an infinite puddle of effective agents.
Since many years, traditional remedies use phyto-
chemicals to treat various diseases because of their
inherent potential to cure diseases [11–16]. Among
the alternative traditional approaches, various plant
products classified as alkaloids, saponins, triterpenes,
glycosides, and polyphenols have shown very prom-
ising anticancer properties in both in vitro and in
vivo [17, 18].
Verbesina encelioides (VE), member of Asteraceae
(Sunflower) family, is native to the United States,
Mexican Plateau, Europe, and Asia including Saudi
Arabia [19]. It is a notorious weed and an ornamental
plant with various bio efficacies like antibacterial, an-
tifungal, antiviral, hypoglycemic and implantation ac-
tivities [20]. Traditionally V. encelioides finds use for
the treatment of sore gums and hemorrhoids [21].
Phytochemical analysis of V. encelioides also revealed
the presence of important primary metabolites, ses-
quiterpenes [22], flavonoids [23], galegine [24] and
triterpenoids [25]. However, our literature survey re-
vealed no published reports on the anticancer poten-
tial of aerial parts of V. encelioides. Thus, the present
investigation aimed to explore the anticancer efficacy
of V. encelioides alcoholic extract on human lung cancer
(A-549), human breast cancer (MCF-7), and human liver
cancer (HepG2) cell lines.
Methods
Cell culture
Human lung cancer (A-549), breast cancer (MCF-7), and
liver cancer (HepG2) cell lines obtained from American
Type Culture Collection (ATCC; Manassas, VA, USA),
were grown in Dulbecco’s modified eagle’s medium
(DMEM) supplemented with 10 % fetal bovine serum
(FBS), 0.2 % sodium bicarbonate, and antibiotic/antimyco-
tic solution (1 ml/100 ml of medium, Invitrogen, Life
Technologies, USA). The cells were maintained in 5 %
CO2 and 95 % atmosphere at 37 °C. Batches of cells show-
ing more than 98 % cell viability were used in the experi-
ments. The cell viability was assessed by trypan blue dye
exclusion assay following the protocol of Pant et al. [26].
Reagents and consumables
All the chemicals, culture mediums, reagents, and kits
were procured from Sigma Chemical Company Pvt. Ltd.,
St. Louis, MO, USA. Culture wares and other plastic
consumables used in the study were procured from
Nunc, Denmark.
Preparation of V. encelioids extract
The V. encelioides plants used in this study were ob-
tained from Harjah, Najran road, Saudi Arabia in Octo-
ber 2013. Dr. Mohammad Atiqur Rahman, taxonomist
of Medicinal, Aromatic, and Poisonous Plants Research
Center (MAPPRC), College of Pharmacy, King Saud
University, Saudi Arabia identified the plants and a
specimen (#16048) is submitted in the herbarium of the
King Saud University. The sundried plants were
ground and extracted with methanol (3 × 10 L) at
room temperature. The combined methanol extract
was evaporated under reduced pressure to obtain a
thick gummy mass. The V. encelioides extract was di-
luted in dimethylsulphoxide (DMSO) for preparation
of the various concentrations for cell viability and
other assays.
Experimental design
A-549, MCF-7, and HepG2 cells were exposed to various
concentrations of (10–1000 μg/ml) of V. encelioides for
24 h. Further, cytotoxic concentrations (250, 500, and
1000 μg/ml) of V. encelioides induced oxidative stress
(GSH and LPO), reactive oxygen species (ROS) gener-
ation, mitochondrial membrane potential (MMP), cell
cycle arrest, and DNA damage in HepG2 cells were
studied.
Cytotoxicity assessments by MTT assay
Percentage cell viability was assessed using the 3-(4, 5-
dimethylthiazol-2-yl)-2, 5-diphenyl tetrazolium bromide
(MTT) assay following the protocol of Siddiqui et al.
[27]. Briefly, 10,000 cells were plated in 96 well plates
and were allowed to adhere in CO2 incubator at 37 °C
for 24 h. Then, cells were exposed to different concen-
trations (10–1000 μg/ml) of V. encelioides extract for
24 h. After the exposure, 10 μl of MTT (5 mg/ml of
stock) was added in each well and plates were incubated
further for 4 h. The supernatant was discarded and
200 μl of DMSO was added in each well and mixed
gently. The developed purple color was read at 550 nm.
Untreated sets run under identical conditions served as
control.
Cytotoxicity assessment by Neutral red uptake (NRU)
assay
NRU assay was carried out following the protocol of
Siddiqui et al. [28]. Briefly, 10,000 cells were plated in 96
well plates and were allowed to adhere in CO2 incubator
at 37 °C for 24 h. Then, cells were exposed to different
concentrations (10–1000 μg/ml) of V. encelioides for
24 h. After the exposure, the medium was aspirated and
cells were washed twice with PBS, and incubated for 3 h
in a medium supplemented with neutral red (50 μg/ml).
The medium was then washed off rapidly with a solution
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containing 0.5 % formaldehyde and 1 % calcium chlor-
ide. Cells were further incubated for 20 min at 37 °C in
a mixture of acetic acid (1 %) and ethanol (50 %) to ex-
tract the dye. The plates were read at 550 nm. The
values were compared with the control sets.
Morphological analysis by phase contrast microscope
Morphological alterations in A-549, MCF-7, and HepG2
cells exposed to V. encelioides extract were observed
under microscope. All the cells were exposed to
10–1000 μg/ml of V. encelioides extract for 24 h.
The cell images were taken using an inverted phase
contrast microscope at 20× magnification.
Lipid peroxidation (LPO)
Lipid peroxidation was performed using thiobarbituric
acid-reactive substances (TBARS) protocol [29]. Briefly,
1 × 105 cells were plated in 6 well plates and were
allowed to adhere in CO2 incubator at 37 °C for 24 h.
Then, cells were exposed to 250–1000 μg/ml of V.
encelioides for 24 h. After the exposure, HepG2 cells
were collected by centrifugation. Then, cells were
sonicated in ice cold potassium chloride (1.15 %)
and centrifuged at 3000 × g for 10 min. Resulting
supernatant (1 ml) was added to 2 ml of thiobarbitu-
ric acid (TBA) reagent (15 % TCA, 0.7 % TBA and
0.25NHCl) and was heated at 100 °C for 15 min in a
boiling water bath. Samples were then placed in cold
ice and were centrifuged at 1000 × g for 10 min.
The absorbance of the supernatant was measured at
550 nm.
Glutathione (GSH) content
Intracellular GSH content was estimated as described
[30]. Briefly, 1 × 105 cells were plated in 6 well plates
and were allowed to adhere in CO2 incubator at 37 °C
for 24 h. Then, cells were exposed to 250–1000 μg/ml of
V. encelioides for 24 h. After the exposure, HepG2 cells
were collected by centrifugation. The cellular protein
was precipitated by incubating 1 ml sonicated cell sus-
pension with 1 ml TCA (10 %) on ice for 1 h, followed
by 10 min centrifugation at 3000 rpm. Then, super-
natant was added to 2 ml of 0.4 M Tris buffer (pH 8.9)
containing 0.02 M EDTA, followed by an addition of
0.01 M 5,5′-dithionitrobenzoic acid (DTNB) to a final
volume of 3 ml. The tubes were incubated at 37 °C for
10 min in a shaking water bath. The absorbance of the
yellow color developed was read at 412 nm.
Reactive oxygen species (ROS) generation
Intracellular ROS generation was detected using the
fluorescent probe DCFH-DA dye, following the proto-
col described by Bakheet et al. [31]. In brief, 2 × 104
cells were plated in 24 well plates and were allowed
to adhere in CO2 incubator at 37 °C for 24 h. Then,
cells were exposed to 250–1000 μg/ml of V. ence-
lioides for 24 h. After the exposure, HepG2 cells
(500 μl) were incubated in the dark with DCFH-DA
(5 μM) for 60 min at 37 °C. Then, cells were immedi-
ately washed twice with PBS and centrifuged at
3600 × g for 5 min at room temperature and cell pel-
lets were further suspended in 500 μl PBS. The fluor-
escence of cells was recorded under 488 nm
excitation. Green fluorescence from DCF was mea-
sured in the FL1 Log channel through a 525 nm
band-pass filter by a Beckman Coulter flow cytometer
(Coulter Epics XL/Xl-MCL, USA). Data were pre-
sented as the mean fluorescence (MnXI) of 10,000
cells.
Mitochondrial membrane potential (MMP)
Flow cytometric measurements of MMP were performed
following the method described by Bakheet et al. [31].
Briefly, 2 × 104 cells were plated in 24 well plates and
were allowed to adhere in CO2 incubator at 37 °C for
24 h. Then, cells were exposed to 250–1000 μg/ml of V.
encelioides for 24 h. After the exposure, control and
treated cells were washed twice with PBS. Then the cells
were further incubated with 5 μg/ml of mitochondrial
specific fluorescent dye Rhodamine-123 for 1 h at 37 °C
in dark. Cells were then washed twice with PBS and fi-
nally responded in 500 μl of PBS to measure the fluores-
cence intensity of Rhodamine-123. The intensity was
measured using flow cytometry and expressed as the
mean fluorescence intensity (MnXI) of 10,000 cells.
Cell cycle analysis
Cell cycle arrest was determined following the method
[32]. In brief, 2 × 104 cells were plated in 24 well plates
and were allowed to adhere in CO2 incubator at 37 °C
for 24 h. HepG2 cells were exposed to different concen-
trations (250–1000 μg/ml) of V. encelioides for 24 h.
After the exposure, cells were harvested and centrifuged
at 3000 rpm for 5 min. Cell pellets were washed in
500 μl of PBS. Then, cells were fixed with 500 μl of
chilled 70 % ethanol, and further incubated at 4 °C for
1 h. After two successive washes with PBS at 3000 rpm
for 5 min, cell pellets were suspended in PBS and stained
with 50 μg propiodium iodide (PI)/ml containing 0.1 %
Triton X-100 and 0.5 mg/ml RNAase A for 1 h at 30 °C
in dark. Fluorescence of the PI was measured by flow
cytometer using Beckman Coulter flow cytometer
(Coulter Epics XL/Xl-MCL, Miami, USA) through a FL-
4 filter (585 nm). For the measurement, 10,000 events
were acquired. The data were analyzed by Coulter Epics
XL/XL-MCL, System II Software, Version 3.0. Cell deb-
ris characterized by a low FSC/SSC was excluded from
the analysis.
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DNA damage by comet assay
DNA strand breaks in HepG2 cells exposed to different
concentrations (250 to 1000 μg/ml) of V. encelioides for
24 h were quantified by comet assay following the
method described [32]. In brief, cells (5 × 104 cells/well)
were exposed to V. encelioides in 24 well plates for 24 h
at 37 °C. The cells were washed with serum free medium
and were harvested by adding 0.065 % trypsin and incu-
bated at 37 °C. The cell suspension was centrifuged at
3000 rpm for 5 min and the pellet was suspended in
100 μl of PBS. The cells were mixed with 100 μl of 1 %
LMA and were layered on one-third frosted slides, pre-
coated with NMA (1 % in PBS) and kept at 4 °C for
10 min. After gelling, another layer of 90 μl of LMA
(0.5 % in PBS) was added. The cells were lysed in a lys-
ing solution overnight. After washing with TBE buffer,
the slides were subjected to electrophoresis in cold TBE
(Tris-base, 90 mM; boric acid, 90 mM; Na2EDTA,
2.5 mM) buffer. Electrophoresis was performed at
1 V/cm for 30 min (16 mA, 32 V) at 4 °C. All pre-
parative steps were conducted in dark to prevent sec-
ondary DNA damage. Each slide was stained with
75 μl of 20 μg/ml ethidium bromide solution for
5 min. The slides were analyzed at 40× magnification
(excitation wavelength of 515–560 nm and emission
wavelength of 590 nm) using a fluorescence micro-
scope (Nikon Eclipse 80i, Japan) coupled with a
charge coupled device (CCD) camera. Images from
100 cells (50 from each replicate slide) were randomly
selected and subjected to image analysis using software
Comet Assay IV (Perceptive Instruments, Suffolk, UK).
Statistical analysis
Results are expressed as mean ± standard error of three
experiments. Statistical analysis was performed using
one-way analysis of variance (ANOVA) and Post-hoc
Dunnett’s test was applied to compare values between
control and treated groups. The values depicting p < 0.05
were considered, as statistically significant.
Results
Cytotoxicity assessment by MTT assay
Figure 1 shows the results of cytotoxicity assessment
of V. encelioides extract in A-549, MCF-7, and HepG2
cell lines obtained using MTT assay. A concentration-
dependent decrease in cell viability was observed in
HepG2 cells following 24 h of exposure to V. ence-
lioides extract. The cell viability at concentrations of
250, 500 and 1000 μg/ml of V. encelioides extract was
measured to be 90, 75 and 53 % in HepG2 cells. Following
exposure to 500 and 1000 μg/ml concentrations of V.
encelioides extract, cell viability was measured to be 87
and 76 % in MCF-7 cells. V. encelioides extract was less
toxic to MCF-7 cells as compared to HepG2 cells and no
cytotoxicity was found even at higher concentrations in
A-549 cells (Fig. 1).
Cytotoxicity assessment byNRU assay
The results obtained using the NRU assay in V.
encelioides extract treated A-549, MCF-7, and
HepG2 cell lines are shown in Additional file 1: Fig-
ure S1. A concentration dependent decrease in the
cell viability of HepG2 cells was observed following
treatment with V. encelioides extract for 24 h. The
percentage cell viability, after exposure of 250, 500
and 1000 μg/ml of V. encelioides was measured to
be 91, 72 and 53 % in HepG2 (Additional file 1:
Figure S1). In MCF-7 cells, cell viability following
treatment with 500 and 1000 μg/ml concentrations
of V. encelioides extract was recorded as 83 and
72 %. However, A-549 cells treated with V. ence-
lioides extract did not cause any decrease in the cell
viability (Additional file 1: Figure S1). Like, MTT
assay the effect of V. encelioides extract was found to be
less toxic to MCF-7 cells as compared to the HepG2 cells
and non-cytotoxic to A-549 cells (Additional file 1:
Figure S1).
Morphological changes
Additional file 2: Figure S2 shows the morphological
changes observed in A-549, MCF-7 and HepG2 cells ex-
posed to different concentrations of V. encelioides for
24 h. Morphological changes were observed using phase
contrast inverted microscope. The cells exposed to
higher doses of V. encelioides extract lost their normal
morphology and shape; these cells appeared more
rounded and less adherent than control. The HepG2
cells indicate the most prominent effects after the expos-
ure of V. encelioides as compared to MCF-7 cells. How-
ever, A-549 cells exposed to V. encelioides extract did
not cause any observable change in the normal morph-
ology of the cells (Additional file 2: Figure S2).
Lipid peroxidation
Figure 2a summarizes the effect on lipid peroxidation
level induced by V. encelioides extract in HepG2 cells. A
concentration dependent statistically significant increase
in lipid peroxidation was observed. An increase of 17,
39, and 49 % was recorded at 250, 500, and 1000 μg/ml
of V. encelioides extract, respectively.
Glutathione depletion
Figure 2b summarizes the decrease in the level of
intracellular glutathione in HepG2 cells treated with
250–1000 μg/ml concentrations of V. encelioides ex-
tract. The results indicate that V. encelioides extract
decreased the glutathione level in a concentration-
dependent manner. The decrease in GSH level was
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observed as 16, 37, and 56 % at 250, 500, and
1000 μg/ml of V. encelioides, respectively as compared
to the control (Fig. 2b).
ROS generation
Figure 3 shows the results obtained from ROS generation
study. A statistically significant (p < 0.01) concentration-
dependent ROS generation was observed in HepG2 cells
treated with V. encelioides extract at 250, 500, and
1000 μg/ml concentrations for 24 h. An increase of
154.63 + 17.55, 150.69 + 3.2, and 704.14 = 20.49 % was ob-
served in ROS generation at 250, 500, and 1000 μg/ml, re-
spectively, as compared to control. However, there was no
significant increase observed between the 250 μg/ml and
500 μg/ml concentrations.
Mitochondrial membrane potential (MMP)
Figure 4 depicts the change in the level of MMP. The ef-
fect of V. encelioides exposure on MMP in HepG2 cells
was evaluated. A concentration dependent statistically
significant (p < 0.01) induction in the level of MMP was
also observed in HepG2 cells after the exposure of V.
encelioides for 24 h. The induction in MMP was observed
to be 128.84 ± 3.8, 129.91 ± 3.6, and 173.71 ± 13.43 % at
100, 250, and 500 μg/ml of V. encelioides, respectively as
compared to untreated control (Fig. 4).
Cell cycle analysis
Figure 5 depicts the flow-cytometric analysis of cell cycle
progression in HepG2 cells exposed to V. encelioides ex-
tract for 24 h. Cell cycle analysis of propiodium iodide
Fig. 2 Verbesina encelioides extract induced oxidative stress in
HepG2 cells exposed for 24 h. a Lipid peroxidation; b Glutathione
depletion. Values are mean ± SE of three independent experiments.
*p < 0.05 and **p < 0.01 versus Control
Fig. 1 Cytotoxicity assessments by MTT assay in A-549, MCF-7, and HepG2 cells. The cells were exposed to different concentrations of Verbesina
encelioides extract for 24 h. Values are the mean ± SE of three independent experiments. *p < 0.05 and **p < 0.01 versus Control
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stained control and V. encelioides extract, treated HepG2
cells indicated an increase in apoptotic G2/M peak. At
the highest concentration of 1000 μg/mlV. encelioides
treated cells showed a significant increase of ~50 % in
G2/M arrest (Fig. 5).
DNA damage by comet assay
Table 1 summarizes the DNA damage measured by the
comet assay parameters i.e., olive tail moment (OTM), tail
length, and tail DNA intensity. The HepG2 cells exposed to
V. encelioides extract for 24 h exhibited significant induc-
tion of DNA damage in a concentration dependent man-
ner. The representative images of DNA damage obtained
by the comet assay are shown in Fig. 6a and b. The HepG2
cells treated with 250, 500, and 1000 μg/ml of V. encelioides
exhibited 2.86-, 3.13-, and 3.2-fold higher OTM values,
1.24-, 1.39, and 1.52-fold higher in tail length, and 1.9-, 2.1-,
and 2.28-fold higher in tail DNA intensity (Table 1).
Fig. 3 Flow cytometric analysis of intracellular ROS generation in HepG2 cells exposed to Verbesina encelioides (VE) extract for 24 h. Panel a shows
the representative spectra of fluorescent DCF as a function of Verbesina encelioides extract concentration. Panel b exhibits the comparative analysis of
the fluorescence enhancement of DCF with increasing concentrations of Verbesina encelioides extract. Each histogram represent the values of
mean ± SD of three independent experiments. *p < 0.05, **p < 0.01 versus control
Fig. 4 Assessment of mitochondrial membrane potential in HepG2 cells exposed to Verbesina encelioides (VE) extract for 24 h. The fluorescence of
Rh123was measured using a flow cytometer on log scale with FL1 filter. Panel a is a representative FACS image decline in the Rh123 fluorescence
as a function of Verbesina encelioides extract concentrations. Each histogram in panel b represents mean ± S.D. values of Rh123 fluorescence
obtained from HepG2 cells exposed to varying concentrations of Verbesina encelioides extract. *p < 0.05, ** p < 0.01 versus control
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Discussion
Natural products are used for the treatment of various
diseases since the beginning of human history. It has
been estimated that approximately 80–85 % of the world
population rely on traditional medicines for their pri-
marily health care and it is known that a major part of
these therapies involves the use of plant extracts or their
active components [17, 33, 34]. Most of the chemother-
apy medicines to treat the cancer diseases are the mole-
cules identified and isolated from plant materials or
their synthetic analogs [35, 36]. Though many researches
have been explored for the advancement to protect
cancer diseases, still there is a need to develop new
drugs to improve the efficacy. The major disadvantages
of available synthetic drugs are their association with the
side effects [37]. Natural therapy, such as use of the
plant products have proved beneficial against the cancer
diseases [38, 39]. Thus, there is a constant demand to
develop effective new anticancer drugs at affordable cost
[36, 40]. Over the last 30 years, natural products have re-
ceived increasing attention for their potential as new
cancer preventive agents [41, 42]. Bearing these facts in
mind, we aimed to examine the anticancer potential of
V. encelioides against three human cancer cell lines, i.e.
lung cancer (A-549), breast cancer (MCF-7), and liver
cancer (HepG2). Further, oxidative stress (GSH and
LPO), reactive oxygen species (ROS) generation, mito-
chondrial membrane potential (MMP), cell cycle arrest,
and DNA damage were also assessed against liver cancer
(HepG2) cells. The results of MTT and NRU assay
showed that the V. encelioides extract exhibited a
concentration-dependent cytotoxic response. The MTT
and NRU assays are commonly used endpoints for cyto-
toxicity assessments, since they evaluate different aspects
of cellular functions and, therefore, can be useful to
examine the potential cytotoxic effects of plant extracts.
Estimation of cytotoxicity is generally based on uptake
or exclusion of dye and are an indicator of the integrity
of the plasma membrane or some intracellular organ-
elles. However, the MTT assay indicates the mitochon-
drial function based on the enzymatic reduction of a
tetrazolium salt by the mitochondrial dehydrogenase of
viable cells [43]. NRU is a measure of lysosomal integrity
Fig. 5 Cell cycle analysis in HepG2 cells exposed to 250–1000 μg/ml concentrations of V. encelioides (VE) extract for 24 h. a Representative flow
cytometric image exhibiting changes in the progression of cell cycle. G2/M in each micrograph represents the percentage of cells in the G2/M
phase. b Each histogram represents the percentage of cells arrested in different phases of cell cycle. **p < 0.001 vs control
Table 1 V. encelioides (VE) extract induced DNA damage in
HepG2 cells after 24 h of exposure, analyzed using different
parameters of alkaline comet assay






Control 0.38 ± 0.02 34.96 ± 3.87 3.75 ± 0.38
VE extract (μg/ml)
250 1.09 ± 0.09* 43.50 ± 2.45* 7.24 ± 0.98*
500 1.19 ± 0.07* 48.55 ± 3.12* 7.84 ± 0.87*
1000 1.23 ± 0.14* 53.26 ± 4.56* 8.55 ± 0.99*
Data represent the mean ± S.D. of three independent experiments done in
duplicate. *p < 0.05 vs. control. Statistical analysis was performed by one-way
analysis of variance (ANOVA) using Dunnett’s multiple comparisons test. The
level of statistical significance chosen was p < 0.05, unless otherwise stated
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since it reflects the capacity of viable cells to incorporate
vital dye into these organelles [44].
The decrease in the cell viability found was specifically
towards MCF-7 and HepG2 cells, whereas no effect was
observed on A-549 cells. Further, the cytotoxic response
was more in HepG2 cells as compared to MCF-7 cells.
The differential cytotoxic response of the V. encelioides
might be due to the specificity of plant towards different
cancer cells, as has been reported previously [45, 46].
Our results are well in ordinance with the other findings
where these kinds of effects are due to the presence of
active components [47]. Our present study demon-
strated that V. encelioides extract showed promising
anti-cancer activity. However, activity was less in MCF-7
cells as compared to HepG2 cells. Thus, HepG2 cells
were selected as a model to further investigate the
underlying mechanism (s) responsible, for this cytotoxic
response. An observable concentration dependent statis-
tically significant increase in lipid peroxidation occurred.
An increase of 17, 39, and 49 % was observed at 250,
500, and 1000 μg/ml of V. encelioides extract, respect-
ively. Oxidative stress is involved in normal cellular pro-
cesses of cell signaling [48]. Many studies have shown
that exposure to natural products promotes cellular oxi-
dative stress which includes lipid peroxidation and de-
pletion in glutathione levels [49, 50]. Data from this
study also showed that V. encelioides induced oxidative
stress in HepG2 cells in a concentration-dependent
manner. An increase in the level of lipid peroxidation
and a decrease in the antioxidant enzyme GSH were ob-
served. These findings suggest that oxidative stress may
be the primary mechanism of the cell death in HepG2
cells when exposed to V. encelioides extract. Previous
reports, suggesting the role of oxidative stress in the cell
death induced by plant extracts [51, 52] firmly support
our results. One of the most common cytotoxic effects
in cancer cells is due to the induction of reactive oxygen
species (ROS) generation [53]. We found that HepG2
cells exposed to V. encelioides extract significantly in-
creased intracellular ROS generation in a concentration-
dependent manner. Our results are also in agreement
with previous findings, where researchers showed ROS
induction due to the treatment of plant extracts [54, 55].
We found an induction in the MMP level in HepG2 cells
treated with V. encelioides extract for 24 h. Reports sug-
gest that high levels of ROS can lead to cellular damage
by resulting in mitochondrial damage, which can then
induce cell death [32]. Induction in MMP level, based
on cationic fluorescent probe Rh123 indicate the role of
oxidative stress and ROS generation in cell death of
HepG2 cells, due to the generation of free radicals dur-
ing the mitochondrial respiration. The results from this
study confirmed that HepG2 cells treated with V. ence-
lioides extract for 24 h significantly activate the G2/M
cell cycle checkpoint as observed by flow-cytometry. Re-
ports reveal that p53 protein is regarded as the guardian
of the cell genome and is able to activate cell cycle
checkpoints, DNA repair and apoptosis to maintain sta-
bility of genome [56]. Flow cytometry analysis of V. ence-
lioides extract treated HepG2 cells suggests the
activation of DNA repair process as observed by cell
cycle arrest in G2/M phase at 250, 500, and 1000 μg/ml
concentration of V. encelioides. It is also known that the
DNA repair mechanisms in the cells are highly con-
served, thus the extensive DNA damage may lead to
cell-cycle arrest and cell death as observed in this
Fig. 6 Verbesina encelioides extract (VE) induced strand breaks in cellular DNA of HepG2 cells. a Representative epi-fluorescence images of DNA
damage in comet assay. b Percent distribution of DNA damage in HepG2 cells exposed to varying concentrations of Verbesina encelioides extract
(VE) for 24 h. Olive tail moment (OTM) values were determined following the algorithm (Olive Tail Moment = (Tail Mean – Head Mean) Tail %
DNA/100) using Comet Assay IV software. **p < 0.01 versus control
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investigation. We have highlighted the DNA damaging
potential of V. encelioides extract in HepG2 cells by
comet assay. The results of Table 1 revealed that the V.
encelioides extract induced a concentration-dependent
significant DNA damage as observed by the induction
in the fold change of olive tail moment (OTM), tail
length, and tail DNA intensity. This V. encelioides ex-
tract induced DNA damage can be explained on the
basis of the experimental evidence of genotoxic po-
tential in HepG2 cells. The DNA damage may either
lead to apoptotic cell death or disrupt the factionaliz-
ing of cells [57–59]. The DNA damage induced in
HepG2 cells indicates the presence of bioactive com-
ponents in V. encelioides extract that are capable of
oxidative DNA damage in cancer cells through their
pro-oxidant mechanism.
Conclusion
The findings from this study, for the first time provide
new understandings on the anticancer potential of
Verbesina encelioides. V. encelioides extract exhibited
differential cytotoxic responses in A-549, MCF-7, and
HepG2 cell lines. The V. encelioides extract exhibit high
cytotoxic response in HepG2 cells as compared to MCF-
7 cells and proved non-cytotoxic in A-549 cells. Results
from this study also entrenched the capacity of V. ence-
lioides extract to induce apoptotic cell death in human
liver cancer (HepG2) cells through oxidative stress, ROS
generation, cell cycle arrest, and DNA damage. Our re-
sults suggest that V. encelioides extract has promising
anticancer potential. Therefore, it can be further used to
develop a new anticancer agent to treat the deadly can-
cer diseases.
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